Analytical and Clinical Validation of Biomarkers for Alzheimers Disease (AD) and AD-Related Dementias (ADRD)?(U01 Clinical Trial Optional)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

View website Save this grant

Next deadline: Jun 5, 2024

Later deadlines: Jul 5, 2024, Oct 5, 2024, Nov 5, 2024, Feb 5, 2025, Mar 5, 2025, Jun 5, 2025, Jul 5, 2025, Oct 5, 2025, Nov 5, 2025, Feb 5, 2026, Mar 5, 2026

Grant amount: Unspecified amount

Fields of work: Dementia & Alzheimer’s Disease

Applicant type: Nonprofit, Government Entity, Indigenous Group, For-Profit Business

Funding uses: Research

Location of project: United States, American Samoa, Guam, Northern Mariana Islands, Puerto Rico Show all

Location of residency: United States, American Samoa, Guam, Northern Mariana Islands, Puerto Rico Show all

Overview:

NOTE: Applicants submitting full proposals for all cycles are encouraged to submit a Letter of Interest by October 3, 2023. LOI's are not required but are highly encouraged. Full proposal deadlines begin November 3, 2023 and are listed below.

The following deadlines apply to standard grant applications (due by 5:00 pm  local time of applicant organization):

  • November 3, 2023
  • February 5 2024
  • June 5, 2024
  • October 5, 2024
  • February 5, 2025
  • June 5 , 2025
  • October 5, 2025
  • February 5, 2026
The following deadlines apply to Renewal/Resubmission/Revision grant applications (due by 5:00 pm local time of applicant organization): 

  • March 5, 2024
  • July 5, 2024
  • November 5, 2024
  • March 5, 2025
  • July 5 , 2025
  • November 5, 2025
  • March 5, 2026
The goal of this Notice of Funding Opportunity (NOFO) is to accelerate the establishment of effective and reliable biomarkers of Alzheimers disease (AD) and AD-related dementias (ADRD) for use in therapy/medical product discovery and development, clinical trials and/or clinical practice. Specifically, this NOFO will support analytical and/or clinical validation of a biomarker, composite biomarker or biomarker signature, with rigor comparable with the expectations described in the Food and Drug Administration (FDA)Biomarker Qualification Program (BQP) or recommended by other FDA regulatory pathways.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

US Dept. of Health & Human Services: National Institutes of Health (NIH)
FUNDER

Your history with this funder
0
SAVED OPPORTUNITIES
No saved opportunities from this funder yet
FUNDER NOTES
Save this opportunity to add notes...
CONTACTS
Save this opportunity to add contacts...

Other Funding Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih)

Forecasted Funding Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih) help icon

Don't miss out on other good fit funders!

Get personalized grant recommendations, tracking and more by creating a free 14-day account.

No credit card required.
instrumentl testimonial face

"Winning 30% more grants thanks to Instrumentl was a huge morale boost. My confidence continues to grow."

Linda Rucker, Grant Writer

This page was last reviewed November 08, 2023 and last updated August 18, 2023